Key Takeaways
- Ruminant Biotech begins a C$7.6 million research program in Alberta.
- Program supported by a C$2.8 million grant from Emissions Reduction Alberta.
- Research aims to validate methane-reducing bolus for pasture-based cattle.
- Initiative supports product registration and future commercialization in Canada.
- Company establishes North American base in Calgary to support expansion.
Ruminant Biotech Advances Canadian Research Initiative
Ruminant Biotech has announced the launch of a C$7.6 million research program focused on validating its methane mitigation solution for pasture-based cattle. The initiative is supported by a C$2.8 million grant from the Government of Alberta through Emissions Reduction Alberta (ERA), along with additional co-funding from industry partners.
The research program marks Ruminant Biotech’s first expansion beyond Australasia. Beginning in August, the company will collaborate with Alberta-based colleges, universities, and federal research facilities to generate data required for product registration and commercialization in Canada.
Tom Breen, CEO of Ruminant Biotech, said the program is designed to demonstrate the effectiveness of the company’s methane reduction solution across Alberta’s beef herd and support regulatory approval for commercial use.
